- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Estimating the budget impact of orphan drugs in Sweden and France 2013–2020 ; volume:9 ; number:1 ; day:13 ; month:2 ; year:2014 ; pages:1-9 ; date:12.2014
Orphanet journal of rare diseases ; 9, Heft 1 (13.2.2014), 1-9, 12.2014
- Creator
-
Hutchings, Adam
- Contributor
-
Schey, Carina
Dutton, Richard
Achana, Felix
Antonov, Karolina
SpringerLink (Online service)
- DOI
-
10.1186/1750-1172-9-22
- URN
-
urn:nbn:de:1111-2016050124684
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hutchings, Adam
- Schey, Carina
- Dutton, Richard
- Achana, Felix
- Antonov, Karolina
- SpringerLink (Online service)
Other Objects (12)
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
Impact of orphan drugs on Latvian budget
Estimating the budget impact of orphan medicines in Europe: 2010 - 2020
Markenführung Orphan Drugs
Predictors of orphan drug approval
Evidenz zu Orphan Drugs : Arbeitspapier
Seltene Helden : Orphan Drugs in Deutschland
Bereitstellung seltener Arzneimittel (Orphan Drugs): Bd. 2
Orphan drug development in rare neurogenetic disorders
Rare diseases and orphan drugs: Latvian story
Mechanism of coordinated access to orphan drugs
Patient access to orphan drugs in France
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
Impact of orphan drugs on Latvian budget
Estimating the budget impact of orphan medicines in Europe: 2010 - 2020
Markenführung Orphan Drugs
Predictors of orphan drug approval
Evidenz zu Orphan Drugs : Arbeitspapier
Seltene Helden : Orphan Drugs in Deutschland
Bereitstellung seltener Arzneimittel (Orphan Drugs): Bd. 2
Orphan drug development in rare neurogenetic disorders
Rare diseases and orphan drugs: Latvian story
Mechanism of coordinated access to orphan drugs
Patient access to orphan drugs in France
Estimating the clinical cost of drug development for orphan versus non-orphan drugs
Impact of orphan drugs on Latvian budget
Estimating the budget impact of orphan medicines in Europe: 2010 - 2020
Markenführung Orphan Drugs
Predictors of orphan drug approval
Evidenz zu Orphan Drugs : Arbeitspapier
Seltene Helden : Orphan Drugs in Deutschland
Bereitstellung seltener Arzneimittel (Orphan Drugs): Bd. 2
Orphan drug development in rare neurogenetic disorders
Rare diseases and orphan drugs: Latvian story
Mechanism of coordinated access to orphan drugs